Biotage AB (publ) (LON:0GRP)

Market Cap	715.73M
Revenue (ttm)	148.39M
Net Income (ttm)	20.50M
Shares Out	n/a
EPS (ttm)	0.26
PE Ratio	34.92
Forward PE	n/a
Dividend	0.12 (0.11%)
Ex-Dividend Date	Apr 26, 2024

Volume	21,206
Average Volume	4,230
Open	131.45
Previous Close	138.90
Day's Range	105.30 - 122.20
52-Week Range	8.90 - 14.57
Beta	0.84
RSI	36.44
Earnings Date	Feb 19, 2025

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicol...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 674
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0GRP

Financial Performance

In 2024, Biotage AB's revenue was 2.06 billion, an increase of 10.42% compared to the previous year's 1.86 billion. Earnings were 284.00 million, an increase of 15.45%.

Financial numbers in SEK